<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04384315</url>
  </required_header>
  <id_info>
    <org_study_id>2019/2544</org_study_id>
    <nct_id>NCT04384315</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Endovenous Radio Frequency (EVRF) for Treatment of Varicose Veins in Singapore</brief_title>
  <acronym>ESVS</acronym>
  <official_title>Pilot Study to Investigate the Efficacy and Safety of Endovenous Radio Frequency (EVRF) for Treatment of Varicose Veins in Singapore</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Singapore General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Singapore General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to report a collaborative, prospective Singaporean experience using
      the Endovenous Radio Frequency® (EVRF®) from F Care Systems (Belgian) for the treatment of
      primary great and short saphenous vein reflux.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators wish to evaluate its safety, efficacy, and performance. Although it has
      been shown to be safe and efficacious in its initial trials, these studies have been limited
      to generally a caucasian-based population, where the vein size, anatomy and distribution of
      venous incompetence can be different from their asian counterparts. The study will evaluate
      the technical, anatomical and clinical performance of EVRF® performed on multiple truncal
      varicose veins, and without mandatory postoperative compression stockings of the GSV, SSV or
      AASV. The two primary endpoints for this evaluation are technical success at the time of the
      procedure, and anatomical success, reported as complete closure at 2-weeks, 3 months, 6
      months and 12 months.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2019</start_date>
  <completion_date type="Anticipated">August 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Technical Success at time of procedure</measure>
    <time_frame>Immediately post-procedure</time_frame>
    <description>Occlusion of treated vein post-procedure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Anatomical Success</measure>
    <time_frame>2 weeks to 12 months post-procedure</time_frame>
    <description>Anatomical success defined as occlusion of treated vessel, as determined by duplex ultrasound.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of Life Score using the EQ-5D questionnaire</measure>
    <time_frame>2 weeks, 3 months, 6 months, 12 months post-procedure</time_frame>
    <description>EQ5D is used to assess quality of life based on Mobility, Self-Care, Usual Activities, Pain/Discomfort and Anxiety, rated at 5 levels: no problems, slight problems, moderate problems, severe problems, unable to perform activity. Inputs from this questionnaire is used to observe for changes in quality of life overtime.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life Score using the Chronic Venous Insufficiency Questionnaire (CIVIQ)</measure>
    <time_frame>2 weeks, 3 months, 6 months, 12 months post-procedure</time_frame>
    <description>CIVIQ is a questionnaire based on three dimensions - pain, physical and psychological, based on a scale from 1 to 5 (no trouble, slight, moderate, considerable, severe). Based on inputs, Global Index Score (GIS) will be tabulated, ranging for 0 to 100 - the higher the value, the poorer the quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life score using the Aberdeen Varicose Vein Questionnaire (AVVQ)</measure>
    <time_frame>2 weeks, 3 months, 6 months, 12 months post-procedure</time_frame>
    <description>To measure health status of varicose veins patients based on symptoms and impact on daily activities. A total score ranging from 0 to 100 will be tabulated, with 100 being worst quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Change using Venous Clinical Severity Score (VCSS)</measure>
    <time_frame>2 weeks, 3 months, 6 months, 12 months post-procedure</time_frame>
    <description>VCSS evaluates the severity of hallmarks of venous disease - 0 (none), 1 (mild), 2 (moderate), 3 (severe).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Score</measure>
    <time_frame>First 10 days post-operation</time_frame>
    <description>Using a numerical rating scale, which ranges from 0 (no pain) to 10 (severe pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time taken to return to work and normal activities</measure>
    <time_frame>10 days post-operation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occlusion rates</measure>
    <time_frame>2 weeks, 3 months, 6 months, 12 months post-procedure</time_frame>
    <description>Duplex ultrasound performed at specific timepoints to ensure that treated vein is occluded</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction with treatment: survey</measure>
    <time_frame>2 weeks, 3 months, 6 months, 12 months post-procedure</time_frame>
    <description>A short survey to assess patient satisfaction and if there are any observed improvement in terms of appearance and symptoms post-procedure.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Varicose Veins</condition>
  <condition>Venous Reflux</condition>
  <condition>Chronic Venous Insufficiency</condition>
  <arm_group>
    <arm_group_label>EVRF</arm_group_label>
    <description>Patients that have undergone Endovenous Radio Frequency® (EVRF®) from F Care Systems (Belgian) for the treatment of primary great and short saphenous vein reflux.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaires</intervention_name>
    <description>Questionnaires to assess the quality of life (EQ-5D, CVVQ, CIVIQ, AVVQ, Patient satisfaction survey)</description>
    <arm_group_label>EVRF</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who will be undergoing Endovenous Radio Frequency® (EVRF®) as a treatment for
        their varicose veins / chronic venous insufficiency
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age &gt;21 years, able to understand the requirements of the study and provide informed
             consent.

          2. C2 - C5 varicose veins / CVI

          3. Symptomatic primaryGSV, SSV or AASV incompetence, with reflux &gt;0.5 seconds on colour
             duplex, including one or more of the following symptoms: aching, throbbing, heaviness,
             fatigue, pruritus, night cramps, restlessness, generalized pain or discomfort,
             swelling.

          4. Patients who has GSV, SSV or AASV diameters of 3mm to 12mm in the standing position.

        Exclusion Criteria:

          1. Current DVT or history of DVT

          2. Recurrent varicose veins

          3. Pregnant patients

          4. Arterial disease (ABPI&lt;0.8)

          5. Sepsis

          6. Patients who are unwilling to participate

          7. Inability or unwillingness to complete questionnaires

          8. Adverse reaction to sclerosant or cyanoacrylate

          9. GSV, SSV or AASV severely tortuous

         10. Life expectancy &lt; 1 year

         11. Active treatment for malignancy other than non-melanoma skin cancer

         12. Current, regular use of systemic anticoagulation (e.g. warfarin, heparin)

         13. Daily use of narcotic analgesia or NSAIDS to control pain associated with venous
             disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Tjun Yip Tang</last_name>
    <role>Principal Investigator</role>
    <affiliation>Singapore General Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Charyl Yap</last_name>
    <phone>65767986</phone>
    <email>charyl.yap.j.q@sgh.com.sg</email>
  </overall_contact>
  <location>
    <facility>
      <name>Singapre General Hospital</name>
      <address>
        <city>Singapore</city>
        <state>Singaopore</state>
        <zip>169608</zip>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charyl Yap</last_name>
      <phone>65767986</phone>
      <email>charyl.yap.j.q@sgh.com.sg</email>
    </contact>
    <investigator>
      <last_name>Tjun Yip Tang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Singapore</country>
  </location_countries>
  <reference>
    <citation>Gloviczki P, Comerota AJ, Dalsing MC, Eklof BG, Gillespie DL, Gloviczki ML, Lohr JM, McLafferty RB, Meissner MH, Murad MH, Padberg FT, Pappas PJ, Passman MA, Raffetto JD, Vasquez MA, Wakefield TW; Society for Vascular Surgery; American Venous Forum. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg. 2011 May;53(5 Suppl):2S-48S. doi: 10.1016/j.jvs.2011.01.079.</citation>
    <PMID>21536172</PMID>
  </reference>
  <reference>
    <citation>Beebe-Dimmer JL, Pfeifer JR, Engle JS, Schottenfeld D. The epidemiology of chronic venous insufficiency and varicose veins. Ann Epidemiol. 2005 Mar;15(3):175-84. Review.</citation>
    <PMID>15723761</PMID>
  </reference>
  <reference>
    <citation>van den Bos R, Arends L, Kockaert M, Neumann M, Nijsten T. Endovenous therapies of lower extremity varicosities: a meta-analysis. J Vasc Surg. 2009 Jan;49(1):230-9. doi: 10.1016/j.jvs.2008.06.030. Epub 2008 Aug 9. Review.</citation>
    <PMID>18692348</PMID>
  </reference>
  <reference>
    <citation>Geza M, Gloviczki P. Venous Embryology and Anatomy. In: Bergan JJ, editor. The Vein Book: Elsivier Academic Press; 2007.</citation>
  </reference>
  <reference>
    <citation>van Eekeren RR, Boersma D, de Vries JP, Zeebregts CJ, Reijnen MM. Update of endovenous treatment modalities for insufficient saphenous veins--a review of literature. Semin Vasc Surg. 2014 Jun;27(2):118-36. doi: 10.1053/j.semvascsurg.2015.02.002. Epub 2015 Feb 18. Review.</citation>
    <PMID>25868763</PMID>
  </reference>
  <reference>
    <citation>Guex JJ. Endovenous chemical (and physical) treatments for varices: what's new? Phlebology. 2014 May;29(1 suppl):45-48. Epub 2014 May 19. Review.</citation>
    <PMID>24843085</PMID>
  </reference>
  <reference>
    <citation>Davies HO, Popplewell M, Darvall K, Bate G, Bradbury AW. A review of randomised controlled trials comparing ultrasound-guided foam sclerotherapy with endothermal ablation for the treatment of great saphenous varicose veins. Phlebology. 2016 May;31(4):234-40. doi: 10.1177/0268355515595194. Epub 2015 Jul 9. Review.</citation>
    <PMID>26163507</PMID>
  </reference>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>April 6, 2020</study_first_submitted>
  <study_first_submitted_qc>May 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 12, 2020</study_first_posted>
  <last_update_submitted>May 10, 2020</last_update_submitted>
  <last_update_submitted_qc>May 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Endovenous Ablation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Venous Insufficiency</mesh_term>
    <mesh_term>Varicose Veins</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>June 4, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/15/NCT04384315/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>June 5, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/15/NCT04384315/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

